Institutional investors purchased a net $1.3 million shares of SNTA during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 33.43% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.3 Million shares of Synta Pharmaceuticals Cor...